Sort
50,496 grants matching “lung cancer”
Oncogenic Met Signaling in Urologic Malignancies
$496,098Donald Bottaro · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Translating Molecular and Clinical Data to Population Lung Cancer Risk Assessment
$496,067Rayjean J. Hung · Baylor College Of Medicine · U19 · FY2021 · CA
Respiratory Motion-Reduced Cone-Beam CT Guidance of Radiotherapy in Lung & Liver
$496,047Gikas S Mageras · Sloan-Kettering Inst Can Research · R01 · FY2009 · CA
Aberrant Glycogen in Lung Adenocarcinoma Tumorigenesis
$496,040Ramon C. Sun · University Of Florida · R01 · FY2022 · CA
Anticancer Agent Pharmacodynamics in Acute Leukemia
$496,004St. Jude Children'S Research Hospital · R01 · FY2005 · CA
Clinical Utility of Salivary ExRNA Biomarkers for Gastric Cancer Detection
$495,999David T Wong · University Of California Los Angeles · UH2 · FY2014 · TR
(PQ8) Predicting immune-related toxicity in the adjuvant melanoma setting with checkpoint inhibition
$495,996Iman Osman · New York University School Of Medicine · R01 · FY2021 · CA
NAPTA: Optimizing clinical trial design & delivery of particle therapy for cancer
$495,990Mack Roach · University Of California, San Francisco · P20 · FY2016 · CA
In vivo therapy and mechanisms of PAX8-PPARgamma thyroid cancer
$495,972Ronald Jay Koenig · University Of Michigan At Ann Arbor · R01 · FY2015 · CA
In vivo therapy and mechanisms of PAX8-PPARgamma thyroid cancer
$495,972Ronald Jay Koenig · University Of Michigan At Ann Arbor · R01 · FY2016 · CA
Cancer patient on a chip
$495,953Gordana Vunjak-Novakovic · Columbia University Health Sciences · R01 · FY2024 · CA
Proteomic determinants of response to checkpoint blockade in malignant pleuralmesothelioma
$495,857Bryan Michael Burt · Baylor College Of Medicine · R37 · FY2023 · CA
3H-pyrazolo[4,3-f]quinoline-containing compounds as selective and tunable protein kinase inhibitors
$495,845Herman O Sintim · Purdue University · R01 · FY2022 · CA
CONTEMPORARY SCREENING FOR THE DETECTION OF LUNG CANCER
$495,812Jonathan G Goldin · University Of California Los Angeles · M01 · FY2006 · RR
Preventive Interventions Leadership U01
$495,793Samir M Hanash · Fred Hutchinson Cancer Research Center · U01 · FY2011 · CA
Risk Factors for Sepsis in the Community
$495,731Henry E Wang · University Of Alabama At Birmingham · R01 · FY2013 · NR
Deregulation of long noncoding RNAs in cancer
$495,683Nadya M Dimitrova · Yale University · R01 · FY2023 · CA
Hermansky Pudlak syndrome & melanosome formation
$495,640Michael S Marks · Children'S Hosp Of Philadelphia · R01 · FY2016 · EY
Mutational Signatures of a Combined Environmental Exposure: Arsenic and Ultraviolet Radiation
$495,601Laurie G Hudson · University Of New Mexico Health Scis Ctr · R01 · FY2024 · ES
Project I: Systems analysis of tumor-stroma interactions in brain metastasis
$495,600Joan Massague · Sloan-Kettering Inst Can Research · U54 · FY2023 · CA
Ah-Receptor as a central mediator of immunomodulation in the tumor microenvironment of breast cancer
$495,598Christoph F A Vogel · University Of California At Davis · R01 · FY2025 · ES
Enhancing Chemoradiation Efficacy through Unbiased Drug Discovery Approaches
$495,509Steven Hsesheng Lin · University Of Tx Md Anderson Can Ctr · U01 · FY2020 · CA
Molecular mechanisms of tumor-initiated premetastatic niche formation in lung str
$495,460Vivek Mittal · Weill Medical Coll Of Cornell Univ · R01 · FY2011 · CA
Lineage heterogeneity and plasticity in lung cancer
$495,420Hideo Watanabe · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · CA
The distinct role of cysteinyl leukotriene receptor for myeloid-derived suppressive cells
$495,420Bin Zhang · Northwestern University At Chicago · R01 · FY2020 · CA